2.69 USD
▼-0.11-3.93%
盘后 2.73 +1.49%
2026-09-15
市值
$90.39M
市盈率
—
EPS
-0.31
股息率
—
52 周区间
2.32 – 5.46
成交量
353.66K
Beta
0.52
目标价
10.00
52W 低 2.3252W 高 5.46
价格走势
公司简介
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to addr...